W2509707469
Mitsuyoshi Nakashima, 貞雄 大口 · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · 1982
S-596, a newly developed, α, β-blocking agent, was orally administered to 6 male healthy volunteers and the time course of pharmacokinetics and pharmacodynamics were studied.Blood pressure and heart rate, at rest, decreased slightly at 2-4 hrs after administration of drug with significant changes. Exercise-induced elevations of systolic blood pressure and tachycardia were suppressed beyond 12 hrs after the administration. Biological half-life of β-blocking activity, based on the declining curves of double products, was 11.2 hrsResting mean velocity of circumferential shortning, ejection fraction and cardiac index showed significant decreases for 4 hrs and these maximums at 2 hrs. Pre-ejection period and PEP/ET showed tendency of increments. Peripheral vascular resistance seemed to increase at 2 hrs but returned to initial levels at 4 hrs.Serum concentration of S-596 reached to the maximum at 2 hrs and the elimination half-life was 7.2 hrs.
Cited by 3 works. doi:10.3999/jscpt.13.495 Open-access PDF
Authors
References
- Relation of Heart Rate and Systolic Blood Pressure to the Onset of Pain in Angina Pectoris
- Use of Propranolol (Inderal) in Treatment of Hypertension
- Immediate Hemodynamic Effects of Beta-Adrenergic Blockade with Propranolol in Normotensive and Hypertensive Man
- Assessment of alpha‐ and beta‐adrenoceptor blocking actions of labetalol.
- Rate-pressure product and myocardial oxygen consumption during surgery for coronary artery bypass.
- Labetalol
- Synthesis and β-Adrenergic Blocking Action of a New Thiazolylthiopropanolamine Derivative
- Labetalol: A Review of its Pharmacology and Therapeutic Use in Hypertension